Novo Nordisk filed a lawsuit against rival Eli Lilly accusing it of using outdated studies to promote its GLP-1 drugs
The maker of Ozempic and Wegovy says its competitor is misleading consumers by citing outdated weight-loss data in advertisements.
The Source
TWSJ
World News
Ukraine’s Battle-Tested Drone Boats to Be Made in U.S. for the First Time
TWSJ·1h ago·3 min read
Business
Fenway Sports Group Mulls Minority Stake Sale of Liverpool Soccer Team
TWSJ·1h ago·3 min read
World News
Opinion | China vs. India Isn’t as Simple as Merit vs. Caste Quotas
TWSJ·2h ago·3 min read
World News
Canada’s Carney Says Trump Agrees to Talks to Avert New 50% Tariff
TWSJ·2h ago·3 min read
Related
On this beat
Health
Cardinal Health’s latest deals won’t move the needle overnight. They still matter.
CNBC·2h ago·3 min read
Health
AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse
CNBC·5h ago·3 min read
Health
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
CNBC·5h ago·3 min read
Health
1,700 H.I.V. Treatment Sites Closed After Trump Aid Cuts, a Study Finds
TNYT·5h ago·3 min read